New Study to Get More Minorities Involved in Genetic Testing
826 articles
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
New Research Sheds Light on Hot and Cold Tumors
Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.
New AI Tool Brings Hope in Quest for Earlier Detection
Can AI help catch pancreatic cancer at an earlier stage? Dr. Michael Rosenthal and others are working on an AI tool to do just that.
A New Approach to Overcome Drug Resistance
Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.
What You Should Know About Tumor Boards
A tumor board brings together experts in different treatment fields to discuss your case and help direct your pancreatic cancer treatment.
2024 AACR Meeting Update
Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.
Reopening America: Guidelines For Pancreatic Cancer Patients
As states begin to reopen their economies, the threat of COVID-19 remains. Dr. Allyson Ocean has recommendations for pancreatic cancer patients.
Taking a Look At FAK Inhibitors
Dr. Conan Kinsey is looking at how FAK inhibitors can make immunotherapy more effective in combination with chemotherapy.
Testing a Different Approach to Pancreatic Cancer Treatment
A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.
A New Approach to Treating Some Advanced Pancreatic Cancer Patients
A clinical trial uses PEGPH20, a synthetic form of a human enzyme, to make treatment more effective in pancreatic cancer patients with high tumor pressure.